HIV/AIDS remains a significant global health challenge, impacting millions of lives worldwide and intersecting profoundly with the Sustainable Development Goals (SDGs) established by the United Nations. The SDGs aim to address global challenges, including health, poverty, inequality, climate change, environmental degradation, peace, and justice. HIV/AIDS intersects with several of these goals but most directly with SDG 3, which aims to ensure healthy lives and promote well-being for all at all ages. Specifically, target 3.3 of the SDGs seeks to end the epidemics of AIDS, tuberculosis, malaria, and neglected tropical diseases by 2030, highlighting the integral relationship between HIV/AIDS eradication efforts and global development objectives.

The battle against HIV/AIDS is intrinsically linked to other SDGs beyond health (SDG 3). For instance, SDG 1 aims to eradicate poverty, which is closely tied to the HIV epidemic; individuals in impoverished communities often lack access to necessary healthcare services, including HIV prevention and treatment, making them more susceptible to the virus. Furthermore, SDG 4, which focuses on quality education, plays a critical role in HIV prevention. Educating individuals about HIV transmission, prevention, and stigma can significantly reduce the virus's spread. Additionally, SDG 5 targets gender equality, which is crucial in the fight against HIV/AIDS. Women and girls often face higher risks and barriers to accessing HIV/AIDS treatment due to gender-based inequalities. Addressing these inequalities is essential for effective HIV prevention and treatment strategies.

Moreover, achieving SDG 10, reduced inequalities, is fundamental in combating HIV/AIDS. Marginalized groups, including people living with HIV, often face discrimination and social stigma, hindering their access to healthcare and support services. By promoting inclusivity and reducing inequalities, communities can better support all individuals affected by HIV/AIDS, thereby enhancing public health outcomes and moving closer to eradicating the disease. The interconnectivity of the SDGs underscores the necessity of a holistic approach to global development challenges. Eradicating HIV/AIDS is not only a matter of addressing health disparities but also involves tackling broader societal issues such as poverty, education, gender inequality, and discrimination. The global community's commitment to the SDGs provides a framework for coordinated efforts to combat HIV/AIDS, showcasing the critical intersection of health and development in achieving a more equitable and healthy world.

Improvements in diagnosis and treatment are enabling people with HIV to liver longer; this study seeks to understand the evolution of comorbidities in an ageing cohort of people with HIV.

World AIDS Day

World AIDS Day, observed annually on 1st December, is an opportunity for people around the globe to unite in the fight against HIV/AIDS, support those affected, and remember those who have lost their lives to the disease.

I. The Importance of World AIDS Day

This Viewpoint supports SDG 3 by discussing how HIV services and primary health care services can be integrated in order to improve HIV outcomes over standalone, siloed HIV care. The reports discusses existing models of integration and the various elements of successful integration.

Trends in Immunology, Volume 44, April 2023

Human immunodeficiency virus and Simian immunodeficiency (SIV) are highly immune evasive viruses with few vulnerabilities. Cytomegalovirus vector-programmed MHC-E-restricted CD8+ T cells can mediate complete replication arrest of primary SIV infection with subsequent viral clearance; this approach may be promising for putative vaccines or immuno-therapeutics against HIV.
This content aligns with Goal 3: Good Health and Wellbeing by highlighting hepatic manifestations of HIV infection.
Graphical abstract
This longitudinal study looks at the aging characteristics of those infected with HIV, and suggests a role for HIV in the earlier onset of clinical aging.
 Alluvial plots denote transitions in oral HPV infection status (any genotype) over the first four study visits in a) HIV+ and b) HIV- participants who had at least 2 valid HPV tests before loss to follow up or completion of 4th visit.
HIV has been shown to increase the likelihood of oral HPV infection. In this study, we evaluated the risk of oral HPV in HIV infected patients compared with HIV-negative controls.
This research highlights the need for thorough informed consent procedures with assessment of comprehension and exploration of personal motives prior to enrollment in cure-related trials